Oruka Therapeutics (ORKA) filed a mixed shelf registration statement late Thursday with the US Securities and Exchange Commission for the sale of up to $1 billion of its securities from time to time.
The securities cover common stock, preferred stock, depository shares and warrants, according to the filing.